NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:30-13:42 |
New Ice Age of Musculoskeletal Intervention: Role of Percutaneous Cryoablation in Bone and Soft Tissue Tumors |
Jun-Jian Huang | Emory University school of medicine, USA |
2 | 13:42-13:54 |
Super-selective TACE |
Seung Boo Yang | Nowon Eulji University Hospital, Korea |
3 | 13:54-14:06 |
Optimizing Outcomes in Centrally Located HCC: The Evolving Role of Precision Radiotherapy |
Wei-Hu Wang | Beijing Cancer Hospital, China |
4 | 14:06-14:18 |
From Vision to Precision: Image-guided Solutions for Interventional Oncology |
Yu Deuerling Zheng | Siemens Healthineers, Germany |
5 | 14:18-14:30 |
Panelists
Hai-Bin Shi
Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China /
Jun-Jian Huang
Emory University school of medicine, USA /
Seung Boo Yang
Nowon Eulji University Hospital, Korea /
Wei-Hu Wang
Beijing Cancer Hospital, China /
Yu Deuerling Zheng
Siemens Healthineers, Germany
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:30-14:45 |
Transradial HepaSphere Treatment for HCC in AMC |
Ji Hoon Shin | Asan Medical Cente, University of Ulsan College of Medicine, Korea |
2 | 14:45-15:00 |
Combined Immuno-DTACE for Difficult-to-treat Liver Cancer Patients |
Alex Tang | Subang Jaya Medical Centre,Malaysia |
3 | 15:00-15:15 |
Advancing Your Practice in Refractory Liver Cancers Management |
Shinichi Hori | Institute for Image Guided Therapy, Japan |
4 | 15:15-15:30 |
Discussion
Jia-Ping Li
The First Affiliated Hospital of Sun Yat-sen University, China /
Zi-Shu Zhang
Xiangya Hospital Central South University, China /
Hai-Bo Shao
The First Affiliated Hospital of China Meical University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:06 |
Does Needle Biopsy Immediately after Percutaneous Microwave and Cryoablation of Lung Neoplasm Affect Pathological Results? A Clinical and Animal Study |
Jun-Ting Ma | First Hospital of China Medical University, China |
2 | 16:06-16:12 |
Outcomes of First-line Microwave Ablation of Treatment-naive Epidermal Growth Factor Receptor–mutated Advanced Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitors |
Sheng Xu | Beijing Hospital, National Center of Gerontology, China |
3 | 16:12-16:18 |
Microwave Ablation versus Lobectomy for Ground-glass Opacity Nodules in the Hilar Region: A Multicenter Prospective Real-world Study on Efficacy and Safety |
Jia-Chang Chi | renji hospital, China |
4 | 16:18-16:24 |
Cryoablation Enhanced Anti-tumor Immunity and Survival for Patients with Liver Metastatic Melanoma Receiving PD-1 Blockade Therapy: Insights from Longitudinal RNA-seq Data |
Chen Li | Sun Yat-sen University Cancer Center, China |
5 | 16:24-16:30 |
Response Evaluation of Liver Directed Therapies for Liver Metastasis in NET |
VARSHA KEDAR | TATA MEMORIAL HOSPITAL, MUMBAI , INDIA |
6 | 16:30-16:36 |
Hepatic Arterial Infusion Chemotherapy with or without Hepatic Artery Chemoembolization for Esophageal Carcinoma Patients with Liver Metastasis: A Clinical Retrospective Study |
Mingrui Yan | Peking University Shougang Hospital,Beijing, China |
7 | 16:36-16:42 |
Drug Eluting Bead Transarterial Chemoembolization (DTACE) Combined with Hepatic Arterial Infusion Chemotherapy versus DTACE Alone for Hepatocellular Carcinoma in Barcelona Clinic Liver Cancer stage C: A Prospective, Multicenter Analysis |
Daqian Han | The First Affiliated Hospital of Zhengzhou University |
8 | 16:42-16:48 |
Comparing Percutaneous and Endoscopic Biliary Drainage in Inoperable Bismuth III/IV Malignant Hilar Biliary Obstruction: Clinical Outcomes and Prognostic Factors |
XIAO-BO FU | Sun Yat-sen University Cancer Center, China |
9 | 16:48-16:54 |
Metformin Suppress Liver Cancer Metastasis by Inhibiting Microwave Ablation Therapy Induced EMT through Modulation of the TGF-β-Smad2/3 Signaling Pathway |
Xian-Mei Liu | Affiliated Hospital of Guizhou Medical University, China |
10 | 16:54-17:00 |
Health Economics Analysis of Three Treatment Methods for Uterine Fibroids |
Yong Jin | The Second Affiliated Hospital of Soochow University, China |
11 | 17:00-17:06 |
Percutaneous Transhepatic Cholangiography in Biliary Obstruction: A Retrospective Audit of Outcomes and Complications |
Sana Sheykhzadeh | Norfolk and Norwich University Hospital |
12 | 17:06-17:12 |
Retrospective Analysis of Diagnostic Accuracy of Image-guided Needle Biopsy of Pancreatic Lesions |
Antariksh Vijan | Tata Memorial Hospital, Mumbai, India |
13 | 17:12-17:18 |
CCL2⁺ Inflammatory Cancer-associated Fibroblasts Promote Chemoresistance and Tumor Progression in Microsatellite Stable Colorectal Cancer via the CCL2-P4HB-NOTCH-STAT3 Axis |
Si-Yuan Weng | National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, China |
14 | 17:18-17:24 |
3D-printed Versatile Biodegradable Biliary Stent with Zinc/Sirolimus for Anti-bacterial and Anti-hyperplasia in a Rabbit Bile Duct |
Jung-Hoon Park | Asan Medical Center, Korea |
15 | 17:24-17:30 |
Neoadjuvant Arterial Infusion Chemotherapy versus Intravenous Chemotherapy for Locally Advanced Gastric Cancer: A Long-term Follow-up |
Jun Chen | Zhejiang Provincial People's Hospital, Hangzhou Medical College, China |
16 | 17:30-17:36 |
Whether the Choice of Location for Re-implantation Chest Port Affects the Incidence of Complications in Adult Tumor Patients Undergoing Right Chest Port Removal |
Cao-Ye Wang | Changzhou First People Hospital, China |
17 | 17:36-17:42 |
Direct Percutaneous Embolization of Hypervascular Renal Cell Cancer Metastasis to the Spine |
Calvin Cheong | National University Hospital, Singapore |
18 | 17:42-17:48 |
Long-term Outcomes of Image-guided Ablation and Laparoscopic Partial Nephrectomy for T1 Renal Cell Carcinoma |
Vinson Chan | University of Leeds, United Kingdom |
19 | 17:48-17:54 |
The Status of Cytotoxic Lymphocytes Indicate Therapeutic Efficacy and Prognosis in Patients with Advanced Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Systemic Therapies |
Hai-Feng Zhou | The First Affiliated Hospital of Nanjing Medical University, China |
20 | 17:54-18:00 |
Transjugular Intrahepatic Portosystemic Shunt Plus Transarterial Chemoembolization of Hepatocellular Carcinoma Patients with Portal Vein Tumour Thrombus-related Variceal Bleeding |
Wei-Zhong Zhou | The first affiliated hospital of Nanjing medical university, China |